The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?
- 1 November 1999
- journal article
- review article
- Published by Elsevier BV in Kidney International
- Vol. 56 (5), 1627-1637
- https://doi.org/10.1046/j.1523-1755.1999.00721.x
Abstract
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?Although the glomerulus, particularly the mesangium, has been the focus of intense investigation in diabetes, tubulointerstitial injury is also a major feature of diabetic nephropathy and an important predictor of renal dysfunction. The renal tubule in diabetes is subject to both direct and indirect pathogenetic influences as a consequence of its position in the nephron and its resorptive function. On exposure to glucose, proximal tubular cells elaborate vasoactive hormones, including angiotensin II and injurious cytokines such as transforming growth factor-β; (TGF-β;), as well as extracellular matrix proteins. In turn, angiotensin II may further increase TGF-β; expression in both proximal tubular and interstitial cells, thus amplifying the stimulus to fibrogenesis in the renal tubulointerstitium. In addition to these mostly direct influences, the renal tubule, particularly its proximal segment, is exposed to glomerular effluent. In the diabetic state, this includes large quantities of advanced glycation end products and glucose and, at later stages in the evolution of diabetic nephropathy, protein, all of which are factors that may induce TGF-β; expression and fibrosis. Diabetic nephropathy should therefore be viewed as a disease affecting the entire nephron. Continued exploration into tubulointerstitial disease in addition to glomerular injury in diabetes may help provide further insights into the pathogenesis of diabetic nephropathy and additional targets for therapeutic interventionKeywords
This publication has 83 references indexed in Scilit:
- Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product bindingKidney International, 1999
- A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR)Kidney International, 1998
- Differential Distribution of Type IV Collagen Chains in Patients with Diabetic Nephropathy in Non-lnsulin-Dependent Diabetes mellitusNephron, 1995
- Polyol pathway mediates high glucose-induced collagen synthesis in proximal tubuleKidney International, 1994
- Renal injury from angiotensin II-mediated hypertension.Hypertension, 1992
- Early increased renal procollagen α1(IV) mRNA levels in streptozotocin induced diabetesKidney International, 1992
- The influence of glucose concentration on angiotensin II-induced hypertrophy of proximal tubular cells in cultureBiochemical and Biophysical Research Communications, 1991
- Prevention of urinary albumin excretion in 6 month streptozocin-diabetic rats with the aldose reductase inhibitor tolrestatJournal of Diabetic Complications, 1988
- Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic ComplicationsNew England Journal of Medicine, 1987
- Effect of Blood Glucose Control on Increased Glomerular Filtration Rate and Kidney Size in Insulin-Dependent DiabetesNew England Journal of Medicine, 1985